Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 935

1.

Replication, Duplication, and Waste in a Quarter Million Systematic Reviews and Meta-Analyses.

Siontis KC, Ioannidis JPA.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e005212. doi: 10.1161/CIRCOUTCOMES.118.005212. No abstract available.

PMID:
30562075
2.

A Comprehensive Analysis of Protocols for Deriving Dopaminergic Neurons from Human Pluripotent Stem Cells.

Marton RM, Ioannidis JPA.

Stem Cells Transl Med. 2018 Dec 10. doi: 10.1002/sctm.18-0088. [Epub ahead of print]

3.

Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies.

Yang T, Li X, Montazeri Z, Little J, Farrington SM, Ioannidis JP, Dunlop MG, Campbell H, Timofeeva M, Theodoratou E.

Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32057. [Epub ahead of print] Review.

PMID:
30536881
4.

Cochrane crisis: secrecy, intolerance, and evidence-based values.

Ioannidis JPA.

Eur J Clin Invest. 2018 Dec 5:e13058. doi: 10.1111/eci.13058. [Epub ahead of print]

PMID:
30520025
5.

Diagnostic accuracy of the Geriatric Depression Scale-30, Geriatric Depression Scale-15, Geriatric Depression Scale-5 and Geriatric Depression Scale-4 for detecting major depression: protocol for a systematic review and individual participant data meta-analysis.

Benedetti A, Wu Y, Levis B, Wilchesky M, Boruff J, Ioannidis JPA, Patten SB, Cuijpers P, Shrier I, Gilbody S, Ismail Z, McMillan D, Mitchell N, Ziegelstein RC, Thombs BD.

BMJ Open. 2018 Dec 4;8(12):e026598. doi: 10.1136/bmjopen-2018-026598.

6.

Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017.

Wallach JD, Boyack KW, Ioannidis JPA.

PLoS Biol. 2018 Nov 20;16(11):e2006930. doi: 10.1371/journal.pbio.2006930. eCollection 2018 Nov.

7.

How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study.

Schuit E, Li AH, Ioannidis JPA.

Int J Epidemiol. 2018 Nov 15. doi: 10.1093/ije/dyy239. [Epub ahead of print]

PMID:
30445577
8.

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: meta-epidemiological analysis.

Ewald H, Speich B, Ladanie A, Bucher HC, Ioannidis JP, Hemkens LG.

J Clin Epidemiol. 2018 Nov 10. pii: S0895-4356(18)30493-1. doi: 10.1016/j.jclinepi.2018.11.001. [Epub ahead of print]

PMID:
30423375
9.

The Challenge of Reforming Nutritional Epidemiologic Research.

Ioannidis JPA.

JAMA. 2018 Sep 11;320(10):969-970. doi: 10.1001/jama.2018.11025. No abstract available.

PMID:
30422271
10.

Correction to: Industry-funded versus non-profit-funded critical care research: a meta-epidemiological overview.

Janiaud P, Cristea IA, Ioannidis JPA.

Intensive Care Med. 2018 Dec;44(12):2323. doi: 10.1007/s00134-018-5437-9.

PMID:
30406805
11.

Extremely large outlier treatment effects may be a footprint of bias in trials from less developed countries: randomized trials of gabapentinoids.

Desai K, Carroll I, Asch S, Hernandez-Boussard T, Ioannidis JPA.

J Clin Epidemiol. 2018 Oct 23. pii: S0895-4356(18)30291-9. doi: 10.1016/j.jclinepi.2018.10.012. [Epub ahead of print]

PMID:
30366063
12.

Professional Societies Should Abstain From Authorship of Guidelines and Disease Definition Statements.

Ioannidis JPA.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e004889. doi: 10.1161/CIRCOUTCOMES.118.004889. No abstract available.

PMID:
30354582
13.

Guidelines Do Not Entangle Practitioners With Unavoidable Conflicts as Authors, and When There Is No Evidence, Just Say So.

Ioannidis JPA.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e005205. doi: 10.1161/CIRCOUTCOMES.118.005205. No abstract available.

PMID:
30354581
14.

Using Big Data to Determine Reference Values for Laboratory Tests-Reply.

Manrai AK, Patel CJ, Ioannidis JPA.

JAMA. 2018 Oct 9;320(14):1496. doi: 10.1001/jama.2018.10956. No abstract available.

PMID:
30304422
15.

Statins and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials.

He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, Timofeeva M, Ioannidis JPA, Campbell H, Theodoratou E.

Ann Intern Med. 2018 Oct 16;169(8):543-553. doi: 10.7326/M18-0808. Epub 2018 Oct 9.

PMID:
30304368
16.

Massive citations to misleading methods and research tools: Matthew effect, quotation error and citation copying.

Ioannidis JPA.

Eur J Epidemiol. 2018 Nov;33(11):1021-1023. doi: 10.1007/s10654-018-0449-x. Epub 2018 Oct 6. No abstract available.

PMID:
30291530
17.

Disclosures Can Always Be Improved-Reply.

Cristea IA, Ioannidis JPA.

JAMA Psychiatry. 2018 Dec 1;75(12):1303-1304. doi: 10.1001/jamapsychiatry.2018.2785. No abstract available.

PMID:
30285040
18.

Rethink Funding.

Ioannidis JPA.

Sci Am. 2018 Sep 18;319(4):52-55. doi: 10.1038/scientificamerican1018-52. No abstract available.

PMID:
30273303
19.

Network meta-analysis of antidepressants - Authors' reply.

Cipriani A, Salanti G, Furukawa TA, Turner E, Ioannidis JPA, Geddes JR.

Lancet. 2018 Sep 22;392(10152):1012-1013. doi: 10.1016/S0140-6736(18)31780-X. Epub 2018 Sep 20. No abstract available.

PMID:
30264703
20.

Precision medicine for individual patients should use population group averages and larger, not smaller, groups.

Djulbegovic B, Ioannidis JPA.

Eur J Clin Invest. 2018 Sep 25:e13031. doi: 10.1111/eci.13031. [Epub ahead of print] No abstract available.

PMID:
30251305

Supplemental Content

Loading ...
Support Center